Interestingly, FABP4 expression also promotes carboplatin resistance in human ovarian cancer cells in culture and when xenografted in mice, indicating that adipocyte-induced FABP4 expression is critical to both growth and survival in the presence of chemotherapy in ovarian tumors (Mukherjee et al., 2020). Here, FABP4 is linked to ovarian carcinoma.